Andrea Loewen - Net Worth and Insider Trading
Andrea Loewen Net Worth
The estimated net worth of Andrea Loewen is at least $5 Million dollars as of 2024-11-13. Andrea Loewen is the SVP, Global Regulatory Affairs of Reata Pharmaceuticals Inc and owns about 28,416 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $5 Million. Details can be seen in Andrea Loewen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrea Loewen has not made any transactions after 2023-09-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrea Loewen
Andrea Loewen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrea Loewen owns 2 companies in total, including Immunic Inc (IMUX) , and Reata Pharmaceuticals Inc (RETA) .
Click here to see the complete history of Andrea Loewen’s form 4 insider trades.
Insider Ownership Summary of Andrea Loewen
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
IMUX | Immunic Inc | 2014-04-16 | See Remarks |
RETA | Reata Pharmaceuticals Inc | 2023-09-26 | SVP & Global Regulatory Affairs |
Andrea Loewen Latest Holdings Summary
Andrea Loewen currently owns a total of 1 stock. Andrea Loewen owns 28,416 shares of Reata Pharmaceuticals Inc (RETA) as of September 14, 2023, with a value of $5 Million.
Latest Holdings of Andrea Loewen
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RETA | Reata Pharmaceuticals Inc | 2023-09-14 | 28,416 | 172.36 | 4,897,782 |
Holding Weightings of Andrea Loewen
Andrea Loewen Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrea Loewen has made a total of 4 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Reata Pharmaceuticals Inc is the sale of 3,175 shares on September 14, 2023, which brought Andrea Loewen around $546,195.
Insider Trading History of Andrea Loewen
- 1
Andrea Loewen Trading Performance
Andrea Loewen Ownership Network
Ownership Network List of Andrea Loewen
Ownership Network Relation of Andrea Loewen
Andrea Loewen Owned Company Details
What does Immunic Inc do?
Who are the key executives at Immunic Inc?
Andrea Loewen is the See Remarks of Immunic Inc. Other key executives at Immunic Inc include director & CEO & President Daniel Vitt , PAO and Controller Glenn Whaley , and Chief Medical Officer Andreas Muehler .
Immunic Inc (IMUX) Insider Trades Summary
Over the past 18 months, Andrea Loewen made no insider transaction in Immunic Inc (IMUX). Other recent insider transactions involving Immunic Inc (IMUX) include a net purchase of 14,000 shares made by Daniel Vitt , and a net purchase of 5,000 shares made by Glenn Whaley .
In summary, during the past 3 months, insiders sold 0 shares of Immunic Inc (IMUX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunic Inc (IMUX) were sold and 19,000 shares were bought by its insiders, resulting in a net purchase of 19,000 shares.
Immunic Inc (IMUX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immunic Inc Insider Transactions
Andrea Loewen Mailing Address
Above is the net worth, insider trading, and ownership report for Andrea Loewen. You might contact Andrea Loewen via mailing address: C/o Vital Therapies, Inc., 15010 Avenue Of Science, Suite 200, San Diego Ca 92128.